Yuanliang Yan

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Endoplasmic Reticulum Stress

Cancer Stem Cells

Signaling Pathway

Top Venues

Disease markers

Journal of oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Xi Chen, Yuanliang Yan, Wang-Rui Liu, Yuanhong Liu, Abhimanyu Thakur, Qiuju Liang, Zhijie Xu
Targeting RAS guanyl releasing protein 1 promotes T lymphocytes infiltrations and improves anti-programmed death receptor ligand 1 therapy response of triple-negative breast cancer. Clinical and translational medicine 13 (7) (2023)
Wei Zhu, Meiyuan Huang, Abhimanyu Thakur, Yuanliang Yan, Xiaoying Wu
FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer. PeerJ 11 (2023)
Wei Zhu, Meiyuan Huang, Abhimanyu Thakur, Yuanliang Yan, Xiaoying Wu
FGF19 promotes cell autophagy and cisplatin chemoresistance by activating MAPK signaling in ovarian cancer. PeerJ 11 (2023)
Fan Zhang, Lixiang Wu, Songshan Feng, Zijin Zhao, Kui Zhang, Abhimanyu Thakur, Zhijie Xu, Qiuju Liang, Yuanhong Liu, Wei Liu, Yuanliang Yan
FHOD1 is upregulated in glioma cells and attenuates ferroptosis of glioma cells by targeting HSPB1 signaling. CNS neuroscience & therapeutics (2023)
Zhilan Li, Qingchun He, Jinwu Peng, Yuanliang Yan, Chencheng Fu
Identification of Downregulated Exosome-Associated Gene ENPP1 as a Novel Lipid Metabolism and Immune-Associated Biomarker for Hepatocellular Carcinoma. Journal of oncology 2022 (2022)
Kuan Hu, Lei Yao, Yuanliang Yan, Lei Zhou, Juanni Li
Comprehensive Analysis of YTH Domain Family in Lung Adenocarcinoma: Expression Profile, Association with Prognostic Value, and Immune Infiltration. Disease markers 2021 (2021)
Zhijie Xu, Shuangshuang Zeng, Zhicheng Gong, Yuanliang Yan
Exosome-based immunotherapy: a promising approach for cancer treatment. Molecular cancer 19 (1) (2020)
Zhijie Xu, Jinzhou Huang, Ming Gao, Guijie Guo, Shuangshuang Zeng, Xi Chen, Xiang Wang, Zhicheng Gong, Yuanliang Yan
Current perspectives on the clinical implications of oxidative RNA damage in aging research: challenges and opportunities. GeroScience 43 (2) (2020)
Xiang Wang, Zhijie Xu, Xinxin Ren, Xi Chen, Jie Wei, Wei Lin, Zhi Li, Chunlin Ou, Zhicheng Gong, Yuanliang Yan
Function of low ADARB1 expression in lung adenocarcinoma. PloS one 14 (9) (2019)